Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease

Chiara Saponaro(University of Pisa), Amalia Gastaldelli(National Research Council), L. Mezzabotta(University of Turin), Antonina Smedile(Ospedale Papa Giovanni XXIII), Demetrio Ciociaro, Maria Lorena Abate(University of Turin), Elisabetta Bugianesi(University of Turin), Federica Carli(Istituto di Fisiologia Clinica), Mario Rizzetto(University of Turin), Francesca Saba(University of Turin), E. Buzzigoli(Istituto di Fisiologia Clinica), Chiara Rosso(University of Turin), Ester Vanni(University of Turin), Melania Gaggini(Istituto di Fisiologia Clinica)
CINECA IRIS Institutial research information system (University of Pisa)
January 1, 2015
Cited by 0

Related Papers

A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
|Hepatology|2003|2.7k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k